tiprankstipranks
Trending News
More News >
Everest Medicines Ltd. (HK:1952)
:1952
Hong Kong Market

Everest Medicines Ltd. (1952) Similar Stocks

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Everest Medicines Ltd.
HK$51.50
HK$17.33B
-22.36
5.42%
0 Buy
1 Hold
0 Sell
Hold
InnoCare Pharma Ltd.
HK$13.54
HK$20.24B
-95.89
128.33%
5 Buy
1 Hold
0 Sell
Strong Buy
Lepu Biopharma Co. Ltd. Class H
HK$5.43
HK$10.09B
-48.22
82.21%
1 Buy
0 Hold
0 Sell
Moderate Buy
Keymed Biosciences, Inc.
HK$62.80
HK$15.58B
-54.25
68.69%
4 Buy
0 Hold
0 Sell
Strong Buy
CARsgen Therapeutics Holdings Ltd.
HK$15.00
HK$8.67B
-15.09
72.61%
0 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Haohai Biological Technology Co., Ltd. Class H
HK$24.90
HK$10.60B
14.18
0.23%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1952
Everest Medicines Ltd.
49.02
2.22
4.74%
HK:9969
InnoCare Pharma Ltd.
13.54
7.61
128.33%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.43
2.78
104.91%
HK:2162
Keymed Biosciences, Inc.
55.50
23.65
74.25%
HK:2171
CARsgen Therapeutics Holdings Ltd.
15.00
6.48
76.06%
HK:6826
Shanghai Haohai Biological Technology Co., Ltd. Class H
25.68
0.16
0.63%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts